Salivary secretory leukocyte protease inhibitor (SLPI) and head and neck cancer: The Cancer Prevention Study II Nutrition Cohort-Reference-Cited by-同舟云学术

Salivary secretory leukocyte protease inhibitor (SLPI) and head and neck cancer: The Cancer Prevention Study II Nutrition Cohort

Published:2016-04 Issue: Volume:55 Page:1-5
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Pierce Campbell Christine M.^ORCID,Giuliano Anna R.,Torres B. Nelson,O’Keefe Michael T.,Ingles Donna J.,Anderson Rebecca L.,Teras Lauren R.,Gapstur Susan M.

Funder

National Cancer Institute

American Cancer Society

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference29 articles.

1. GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11 [Internet];Ferlay,2013

2. Epidemiology and clinical aspects of HPV in head and neck cancers;Chaturvedi;Head Neck Pathol,2012

3. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review;Kreimer;Cancer Epidemiol Biomar Prev,2005

4. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing;Ashcroft;Nat Med,2000

5. Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor;Doumas;Infect Immun,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. scDiffCoAM: A complete framework to identify potential biomarkers for esophageal squamous cell carcinoma using scRNA-Seq data analysis;Journal of Biosciences;2024-08-06

2. Diversity and compositional differences in the oral microbiome of oral squamous cell carcinoma patients and healthy controls: a scoping review;Frontiers in Oral Health;2024-06-11

3. Salivary Protein Biomarkers for Diagnosis of Oral Squamous Cell Carcinoma;Current Cancer Drug Targets;2024-01

4. The secretory leukocyte protease inhibitor (SLPI) in pathophysiology of non-communicable diseases: Evidence from experimental studies to clinical applications;Heliyon;2024-01

5. Secretory leukocyte protease inhibitor (SLPI) in cancer pathophysiology: Mechanisms of action and clinical implications;Pathology - Research and Practice;2023-08